Alessia Bottos

4PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2026
Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO.

|Jan 22, 2026
Molecular features of response and resistance to glofitamab, a T-cell engager for treatment of large B-cell lymphoma.

Stephan Schmeing, Sina Nassiri, Gabrielle Leclercq-Cohen

|Oct 20, 2025
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.

Martin Hutchings, Anna Sureda, Francesc Bosch

|Apr 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.

Michal Marek Hoppe, Patrick Jaynes, Fan Shuangyi

Pageof 1

Frequent Collaborators

1 joint publications

Michal Marek Hoppe

1 joint publications

Patrick Jaynes

1 joint publications

Fan Shuangyi

1 joint publications

Yanfen Peng